姓名：江涛 性别：男 职称：主任医师、教授 招生院所：神经外科研究所 招生类型：科学与专业学位(博) 科学与专业学位(硕) 招生专业：外科学（神外）(博) 外科学（神外）(硕) 研究方向名称：脑胶质瘤精准医疗 电子信箱：taojiang1964@163.com


社会任职
1. 中华医学会会员
2. 美国神经肿瘤学会会员
3. 中华医学杂志审稿人
4. 中华神经外科学杂志审稿人
5. 中国微侵袭神经外科学杂志编委
6. 中华实验外科学杂志编委
7. 中国医师协会神经外科医师协会会员
8. 中国神经肿瘤专家委员会委员
9. 首都医科大学肿瘤学系学术委员会
10. 中华医学会神经外科学分会神经肿瘤学组副组长
11. 中国药学会药物应用分会肿瘤药物应用学组组长
12. 中国脑胶质瘤协作组组长
13. Neuro-oncology杂志编委
14. Neural Regeneration Research杂志编委
15. Chinese Journal of Cancer Research杂志编委
16. Plos one 杂志学术编辑
17. Current Signal Transduction Therapy亚洲区主编
18. 中华神经外科杂志编委
19. Chinese Neurosurgical Journal编委
20. 中国医师协会脑胶质瘤专业委员会主任委员
21. 中国医师协会整合医学医师分会整合神经外科学专业委员会（学组）常务委员
22. 首都医科大学神经外科学院第三届院务委员会副院长
个人简历
1. 199109-199607:哈尔滨医科大学 研究生学习（硕博连读）
2. 199609-199807:北京市神经外科研究所 博士后工作
3. 199809-200202:首都医科大学附属北京天坛医院 副主任医师
4. 200202-200402:MD Anderson Cancer Center（USA） 访问
5. 200407-:首都医科大学附属北京天坛医院 主任医师
6. 200407-:首都医科大学附属北京市神经外科研究所 分子神经病理室 副主任
7. 200805-:首都医科大学肿瘤学系 副主任
8. 2013-:首都医科大学附属北京天坛医院神经外科中心 副主任
9. 2013-:北京脑重大疾病研究院脑肿瘤研究所 副所长
10. 2013-:北京市神经外科研究所 副所长
11. 2013-:北京市神经外科研究所 神经分子病理室 主任
重要学术论文
1. Yu-Qing Liu#, Rui-Chao Chai#, Yong-Zhi Wang, Zheng Wang, Xing Liu, Fan Wu*, Tao Jiang*.Amino acid metabolism-related gene expression-based risk signature can better predict overall survival for glioma. Cancer Science. 2019,110(1):321-333.SCI
2. Chong Qi#, Yiming Li#, Xing Fan, Yin Jiang, Rui Wang, Song Yang, Lanxi Meng, Tao Jiang*, Shaowu Li*.A quantitative SVM approach potentially improves the accuracy of magnetic resonance spectroscopy in the preoperative evaluation of the grades of diffuse gliomas. NeuroImage: Clinical. 2019,23(101835):1-7.SCI
3. 国家卫生健康委员会医政医管局，江涛*.脑胶质瘤诊疗规范（2018 年版）. 中华神经外科杂志. 2019,35(3):217-239.核心期刊
4. Zheng Zhao#, Ke-Nan Zhang#, Rui-Chao Chai#, Kuan-Yu Wang#, Ruo-Yu Huang, Guan-Zhang Li, Yong-Zhi Wang, Jing Chen*, Tao Jiang*.ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme. Disease Markers. 2019,2019(0):**.SCI
5. Zhi-Liang Wang#, Zheng Wang, Guan-Zhang Li, Qiang-Wei Wang, Zhao-Shi Bao, Chuan-Bao Zhang*, Tao Jiang*.Immune Cytolytic Activity Is Associated With Genetic and ClinicalProperties of Glioma. Frontiers in Immunology. 2019,8(10):1756.SCI
6. Fan Wu#, Zheng Zhao#, Rui-Chao Chai#, Yu-Qing Liu, Guan-Zhang Li, Hao-Yu Jiang, Tao Jiang*.Prognostic power of a lipid metabolism gene panel for diffuse gliomas. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2019,23(11):7741-7748.SCI
7. Zhi-Liang Wang#, Chuan-Bao Zhang, Yu-Qing Liu, Zheng Wang*, Tao Jiang*.Peripheral blood test provides a practical method for glioma evaluation and prognosis prediction. CNS Neurosci Ther. 2019,8(8):876-883.SCI
8. Zhi-Liang Wang#, Zheng Zhao, Zheng Wang*, Chuan-Bao Zhang*, Tao Jiang*.Predicting chromosome 1p/19q codeletion by RNA expression profile: a comparison of current prediction models. Aging-US. 2019,11(3):974-985.SCI
9. Zhi-Liang Wang#, Guan-Zhang Li, Qiang-Wei Wang, Zhao-Shi Bao, Zheng Wang*, Chuan-Bao Zhang*, Tao Jiang*.PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor. ONCOIMMUNOLOGY. 2019,11(8):e**-2.SCI
10. Shuli Liang#, Xing Fan#, Ming Zhao, Xia Shan, Wenling Li, Ping Ding, Gan You, Zhen Hong, Xuejun Yang, Guoming Luan, Wenbin Ma, Hui Yang, Yongpin You, Tianming Yang, Liang Li, Weiping Liao, Lei Wang, Xun Wu, Xinguang Yu, Jianguo Zhang, Qing Mao, Yuping Wang, Wenbin Li, Xuefeng Wang, Chuanlu Jiang, Xi.Clinical practice guidelines for the diagnosis and treatment of adult diffuse glioma-related epilepsy. Cancer medicine. 2019,8(10):4527-4535.SCI
11. Guan-Zhang Li #, Ke-Nan Zhang #, Zheng Wang, Hui-Min Hu, Zhi-Liang Wang, Ruo-Yu Huang, Hao-Yu Jiang, You Zhai, Yue-Mei Feng, Yuan-Hao Chang, Ren-Peng Li, Fan Wu, Fan Zeng, Tao Jiang*, Wei Zhang*.Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy. OncoTargets and Therapy. 2019,0(12):10263–10273.SCI
12. Rui-Chao Chai#, Ke-Nan Zhang, Yu-Zhou Chang, Fan Wu, Yu-Qing Liu, Zheng Zhao, Kuan-Yu Wang, Yuan-Hao Chang, Tao Jiang*, Yong-Zhi Wang*.Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma. Carcinogenesis. 2019,40(10):1229-1239.SCI
13. Kai Huang#, Xing Liu#, Yansheng Li#, Qixue Wang, Junhu Zhou, Yunfei Wang, Feng Dong, Chao Yang, Zhiyan Sun, Chuan Fang, Chaoyong Liu, Yanli Tan, Xudong Wu*, Tao Jiang*, Chunsheng Kang*.Genome-Wide CRISPR-Cas9 Screening Identifies NF-κB/E2F6 Responsible for EGFRvIII-Associated Temozolomide Resistance in Glioblastoma. advanced science. 2019,2019(6):** (1 of 16).SCI
14. L. Jingshan, F. Shengyu, F. Xing, W. Zheng, Z. Chuanbao, Q. Zenghui, L. Xing, S. Lihua, L. Guanzhang, Y. Fuqiang, J. Shuai, W. Yinyan, and J. Tao*.Morphometry of the Hand Knob Region and Motor Function Change in Eloquent Area Glioma Patients. Clin Neuroradiol. 2018,【未填写卷（期）】:【未填写起止页码】.SCI
15. Z. Wang, X. Liu, Z. Wang, Z. Bao, W. Zhang, C. Zhang, and T. Jiang*.Identification of a Good-Prognosis IDH-Mutant-Like Population of Patients with Diffuse Gliomas. Curr Mol Med. 2018,17(7): :518-526..SCI
16. X. Ding#, Z. Wang#, D. Chen#, Y. Wang#, Z. Zhao, C. Sun, D. Chen, C. Tang, J. Xiong, L. Chen, Z. Yao, Y. Liu, X. Wang, D. P. Cahill, J. F. de Groot*, T. Jiang*, Y. Yao*, and L. Zhou. .The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective study. J Neurooncol.. 2018,140(3):591-603.SCI
17. Hu H#, Mu Q#, Bao Z#, Chen Y#, Liu Y#, Chen J, Wang K, Wang Z, Nam Y, Jiang B, Sa JK, Cho HJ, Her NG, Zhang C, Zhao Z, Zhang Y, Zeng F, Wu F, Kang X, Liu Y, Qian Z, Wang Z, Huang R, Wang Q, Zhang W, Qiu X, Li W, Nam DH, Fan X*, Wang J*, Jiang T*.Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor. Cell. 2018,175(6):1665-1678.SCI
18. G. Li#, Y. Li#, X. Liu, Z. Wang, C. Zhang, F. Wu, H. Jiang, W. Zhang, Z. Bao, Y. Wang, J. Cai, L. Zhao, U. D. Kahlert, T. Jiang*, and W. Zhang*.ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma. Cell Death Dis.. 2018,9(12):1190.SCI
19. G. Li#, Z. Wang#, C. Zhang, X. Liu, F. Yang, L. Sun, J. Liang, H. Hu, Y. Liu, G. You, Z. Bao, W. Zhang, Z. Wang*, and T. Jiang*..MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status. Dis Markers. 2018,2018:**.SCI
20. Y. Li#, X. Liu#, K. Xu, Z. Qian, K. Wang, X. Fan, S. Li, Y. Wang*, and T. Jiang*. .MRI features can predict EGFR expression in lower grade gliomas: A voxel-based radiomic analysis. Eur Radiol. 2018,28(1):356-362.SCI
21. S. Liu, X. Fan, C. Zhang, Z. Wang, S. Li, Y. Wang, X. Qiu*, and T. Jiang*.MR imaging based fractal analysis for differentiating primary CNS lymphoma and glioblastoma. Eur Radiol. 2018,29(3):1348-1354.SCI
22. Y. Li#, X. Liu#, Z. Qian, Z. Sun, K. Xu, K. Wang, X. Fan, Z. Zhang, S. Li, Y. Wang*, and T. Jiang*..Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature. Eur Radiol. 2018,28(7):2960-2968.SCI
23. S. Liu#, Z. Wang#, Y. Wang, X. Fan, C. Zhang, W. Ma, X. Qiu#, and T. Jiang#. .PD-1 related transcriptome profile and clinical outcome in diffuse gliomas. Oncoimmunology. 2018,7(2):e**.SCI
24. X. Liu#, Y. Li#, Z. Qian, Z. Sun, K. Xu, K. Wang, S. Liu, X. Fan, S. Li, Z. Zhang, T. Jiang*, and Y. Wang*..A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas. Neuroimage Clin.. 2018,20:1070-1077.SCI
25. X. Liu#, Y. Li#, Z. Sun, S. Li, K. Wang, X. Fan, Y. Liu, L. Wang, Y. Wang*, and T. Jiang*. .Molecular profiles of tumor contrast enhancement: A radiogenomic analysis in anaplastic gliomas.. Cancer Med.. 2018,7(9):4273-4283.SCI
26. Z. Liu#, Y. Wang#, X. Liu#, Y. Du, Z. Tang, K. Wang, J. Wei, D. Dong, Y. Zang, J. Dai, T. Jiang*, and J. Tian*.Radiomics analysis allows for precise prediction of epilepsy in patients with low-grade gliomas.. Neuroimage Clin.. 2018,17:271-278.SCI
27. Z. Qian, Y. Li, X. Fan, C. Zhang, Y. Wang*, T. Jiang*, and X. Liu*..Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.. J Neurooncol. 2018,137(1):127-137.SCI
28. Z. Qian#, Y. Li#, Z. Sun, X. Fan, K. Xu, K. Wang, S. Li, Z. Zhang, T. Jiang*, X. Liu*, and Y. Wang*. .Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction. Aging (Albany NY).. 2018,10(10):2884-2899.SCI
29. Y. Li#, X. Liu#, K. Xu, Z. Qian, K. Wang, X. Fan, S. Li, Y. Wang*, and T. Jiang*. .MRI features can predict EGFR expression in lower grade gliomas: A voxel-based radiomic analysis. Eur Radiol. 2018,28(1):356-362.SCI
30. Y. Li, Z. Qian, K. Xu, K. Wang, X. Fan, S. Li, T. Jiang*, X. Liu*, and Y. Wang*..MRI features predict p53 status in lower-grade gliomas via a machine-learning approach. Neuroimage Clin. 2018,17:306-311.SCI
31. K. Wang#, R. Huang#, G. Li, F. Zeng, Z. Zhao, Y. Liu, H. Hu*, and T. Jiang*.CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in highgrade glioma. Oncol Rep. 2018,40(4):2036-2046.SCI
32. K. Wang#, Y. Wang#, X. Fan, Y. Li, X. Liu, J. Wang, L. Ai, J. Dai, and T. Jiang*.Regional specificity of 1p/19q co-deletion combined with radiological features for predicting the survival outcomes of anaplastic oligodendroglial tumor patients. J Neurooncol.. 2018,136(3):523-531.SCI
33. Q. Wang#, Z. Wang#, G. Li, C. Zhang, Z. Bao, Z. Wang*, G. You*, and T. Jiang*. .Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling. Aging (Albany NY). 2018,10(8):1977-1988.SCI
34. Z. Wang, X. Liu, Z. Wang, Z. Bao, W. Zhang, C. Zhang*, and T. Jiang*.Identification of a Good-Prognosis IDH-Mutant-Like Population of Patients with Diffuse Gliomas.. Curr Mol Med.. 2018,17(7):518-526.SCI
35. Z. Qian, Y. Li, X. Fan, C. Zhang, Y. Wang, T. Jiang*, and X. Liu..Molecular and clinical characterization of IDH associated immune signature in lower-grade gliomas.. Oncoimmunology. 2018,7(6):e**.SCI
36. F. Yang, X. Liu, Y. Liu, Y. Liu, C. Zhang, Z. Wang, T. Jiang*, and Y. Wang.miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-kappaB pathways in glioblastoma. Cancer Lett. 2017,396(1）:【未填写起止页码】.SCI
37. F. Wu, C. Zhang, J. Cai, F. Yang, T. Liang, X. Yan, H. Wang, W. Wang, J. Chen, and T. Jiang*.Upregulation of long noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor prognosis in glioma. Oncotarget. 2017, 8(32):: 53110-53123.SCI
38. Z. Wang, Y. Hao, C. Zhang, Z. Wang, X. Liu, G. Li, L. Sun, J. Liang, J. Luo, D. Zhou, R. Chen, and T. Jiang*.The Landscape of Viral Expression Reveals Clinically Relevant Viruses with Potential Capability of Promoting Malignancy in Lower-Grade Glioma. Clin Cancer Res. 2017,23(9): :2177-2185..SCI
39. C. Qi, S. Yang, L. Meng, H. Chen, Z. Li, S. Wang, T. Jiang*, and S. Li..Evaluation of cerebral glioma using 3T diffusion kurtosis tensor imaging and the relationship between diffusion kurtosis metrics and tumor cellularity. J Int Med Res. 2017,45（4）:1347-1358.SCI
40. H. Hu, Z. Wang, M. Li, F. Zeng, K. Wang, R. Huang, H. Wang, F. Yang, T. Liang, H. Huang, and T. Jiang*.Gene Expression and Methylation Analyses Suggest DCTD as a Prognostic Factor in Malignant Glioma. Sci Rep. 2017,7(1):11568.
41. S. Fang, J. Liang, T. Qian, Y. Wang, X. Liu, X. Fan, S. Li, Y. Wang, and T. Jiang*..Anatomic Location of Tumor Predicts the Accuracy of Motor Function Localization in Diffuse Lower-Grade Gliomas Involving the Hand Knob Area. AJNR Am J Neuroradiol,. 2017,38(10):1990-1997.SCI
42. Y. Li, X. Liu, K. Xu, Z. Qian, K. Wang, X. Fan, S. Li, Y. Wang, and T. Jiang*.MRI features can predict EGFR expression in lower grade gliomas: A voxel-based radiomic analysis. Eur Radiol. 2017,【未填写卷（期）】:【未填写起止页码】.
43. Y. Li, Z. Qian, K. Xu, K. Wang, X. Fan, S. Li, X. Liu, Y. Wang, and T. Jiang*. Radiomic features predict Ki-67 expression level and survival in lower grade gliomas. J Neurooncol. 2017,【未填写卷（期）】:【未填写起止页码】.SCI
44. X. Shan, X. Fan, X. Liu, Z. Zhao, Y. Wang, and T. Jiang*.Clinical characteristics associated with postoperative seizure control in adult low-grade gliomas: a systematic review and meta-analysis. Neuro Oncol. 2017,【未填写卷（期）】:【未填写起止页码】.SCI
45. L. H. Sun, F. Q. Yang, C. B. Zhang, Y. P. Wu, J. S. Liang, S. Jin, Z. Wang, H. J. Wang, Z. S. Bao, Z. X. Yang, and T. Jiang*.Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma. CNS Neurosci Ther. 2017,23(1): :69-75.SCI
46. Y. Wang, Y. Wang, X. Fan, S. Li, X. Liu, J. Wang, and T. Jiang*.Putamen involvement and survival outcomes in patients with insular low-grade gliomas. J Neurosurg. 2017,126(6):1788-1794.SCI
47. Z. Zhao, F. Meng, W. Wang, Z. Wang, C. Zhang, and T. Jiang*.Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas. Sci Data. 2017,4(170024.:【未填写起止页码】.SCI
48. T Jiang, Y Mao, W Ma, Q Mao, Y You, X Yang, C Jiang, C Kang, X Li, L Chen, X Qiu, W Wang, W Li, Y Yao, S Li, S Li, A Wu, K Sai, H Bai, G Li, B Chen, K Yao, X Wei, X Liu, Z Zhang, Y Dai, S Lv, L Wang, Z Lin, J Dong, G Xu, X Ma, J Cai, W Zhang, H Wang, L Chen, C Zhang, P Yang, W Yan, Z Liu, H Hu, J.CGCG clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett. 2016,375(2):263-73.SCI
49. M Y Li, P Yang, Y W Liu, C B Zhang, K Y Wang, Y Y Wang, K Yao, W Zhang, X G Qiu, W B Li, X X Peng, Y Z Wang, and T Jiang*.Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas. Sci Rep. 2016,6:21141.SCI
50. Y Liu, H Hu, C Zhang, Z Wang, M Li, and T Jiang*. Integrated analysis identified genes associated with a favorable prognosis in oligodendrogliomas. Genes Chromosomes Cancer. 2016,55(2):169-76.SCI
51. Y Wang, K Wang, J Wang, S Li, J Ma, J Dai, and T Jiang*.Identifying the association between contrast enhancement pattern, surgical resection, and prognosis in anaplastic glioma patients. Neuroradiology. 2016,58(4): 367-74.SCI
52. P Yang, J Cai, W Yan, W Zhang, Y Wang, B Chen, G Li, S Li, C Wu, K Yao, W Li, X Peng, Y You, L Chen, C Jiang, X Qiu, T Jiang*, and C project.Classification based on mutations of TERT promoter and IDH characterizes subtypes in grade IIIII gliomas. Neuro Oncol. 2016,18(8):1099-1108.SCI
53. Z Wang, C Zhang, L Sun, J Liang, X Liu, G Li, K Yao, W Zhang, and T Jiang*.FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients. Oncotarget. 2016,7（51）:84587-84593.SCI
54. Z Wang, C Zhang, X Liu, Z Wang, L Sun, G Li, J Liang, H Hu, Y Liu, W Zhang, and T Jiang*.Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma. Oncoimmunology. 2016, e**:【未填写起止页码】.SCI
55. S Fang, Y Wang, and T Jiang*.The Influence of Frontal Lobe Tumors and Surgical Treatment on Advanced Cognitive Functions. . World Neurosurg. 2016,91:340-346.SCI
56. P Yang, T Liang, C Zhang, J Cai, W Zhang, B Chen, X Qiu, K Yao, G Li, H Wang, C Jiang, G You, and T Jiang*.Clinicopathological factors predictive of postoperative seizures in patients with gliomas. Seizure. 2016,35(2016):93-99.SCI
57. Yang, P#. Zhang, W#. Wang, Y. Peng, X. Chen, B. Qiu, X. Li, G. Li, S. Wu, C. Yao, K. Li, W. Yan, W. Li, J. You, Y. Chen, C. C. Jiang, T*.IDH mutation and MGMT promoter methylation in glioblastoma results of a prospective registry. Oncotarget. 2016,6(38):40896-40906.SCI
58. X Fan, Y Wang, Y Liu, X Liu, C Zhang, L Wang, S Li, J Ma, and T Jiang*.Brain regions associated with telomerase reverse transcriptase promoter mutations in primary glioblastomas. J Neurooncol. 2016,128(3):455-462..SCI
59. Wang K, Wang YY, Wang JF, Ma J, Jiang T*, Dai JP..Radiologic Features and Expression of Vascular Endothelial Growth Factor Stratify Survival Outcomes in Patients with Glioblastoma. AJNR Am J Neuroradiol. 2016,37（2016）:629-935.SCI
60. J Cai, P Zhu, C Zhang, Q Li, Z Wang, G Li, G Wang, P Yang, J Li, B Han, C Jiang*, Y Sun*, and T Jiang*.Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas. Oncotarget. 2016,7（13）:16384-16395.SCI
61. X Fan, Y Wang, K Wang, S Liu, Y Liu, J Ma, S Li, and T Jiang.Anatomical specificity of vascular endothelial growth factor expression in glioblastomas: a voxel-based mapping analysis. Neuroradiology. 2016,58(1):69-75.SCI
62. X Fan, Y Wang, C Zhang, X Liu, Z Qian, and T Jiang*. Human leukocyte antigen-G overexpression predicts poor clinical outcomes in low-grade gliomas. J Neuroimmunol. 2016, 294:27-31.SCI
63. S Liu, Y Wang, X Fan, J Ma, W Ma, R Wang, and T Jiang.Anatomical Involvement of the Subventricular Zone Predicts Poor Survival Outcome in Low-Grade Astrocytomas. PLoS One. 2016,11(4):e**.SCI
64. K Wang, Y Wang, X Fan, J Wang, G Li, J Ma, J Ma, T Jiang*, and J Dai*.Radiological features combined with IDH1 status for predicting the survival outcome of glioblastoma patients. Neuro Oncol. 2016,18(4):589-97.SCI
65. Y Liu, H Hu, C Zhang, H Wang, W Zhang, Z Wang, M Li, W Zhang, D Zhou*, and T Jiang*.Co-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomas. Oncotarget. 2015,6(35):38257-69.SCI
66. Y Wang, S Liu, X Fan, S Li, R Wang, L Wang, J Ma*, T Jiang*, and W Ma*.Age-associated brain regions in gliomas: a volumetric analysis. J Neurooncol. 2015,123(2):299-306.SCI
67. J Cai, W Zhang, P Yang, Y Wang, M Li, C Zhang, Z Wang, H Hu, Y Liu, Q Li, J Wen, B Sun, X Wang, T Jiang*. Identification of a 6-cytokine prognostic signature in patients with primary glioblastoma harboring m2 microglia/macrophage phenotype relevance. PLoS One. 2015,10(5):e**.SCI
68. X Fan, Y Y Wang, C B Zhang, G You, M Y Li, L Wang*, and T Jiang*.Expression of RINT1 predicts seizure occurrence and outcomes in patients with low-grade gliomas. J Cancer Res ClinOncol. 2015,141(4):729-34.SCI
69. Y Wang, X Fan, H Li, Z Lin, H Bao, S Li, L Wang, T Jiang, Y Fan*, and T Jiang*.Tumor border sharpness correlates with HLA-G expression in low-grade gliomas. J Neuroimmunol. 2015,282:1-6.SCI
70. Y Wang, T Qian, G You, X Peng, C Chen, Y You, K Yao, C Wu, J Ma, Z Sha, S Wang*, and T Jiang*. Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping. Neuro Oncol. 2015,17(2):282-8.SCI
71. Y Wang, K Wang, H Li, J Wang, L Wang, J Dai, T Jiang*, and J Ma*. Identifying the association of contrast enhancement with vascular endothelia growth factor expression in anaplastic gliomas: a volumetric magnetic resonance imaging analysis. PLoS One. 2015,10(3):e**.SCI
72. Y Wang, T Zhang, S Li, X Fan, J Ma, L Wang*, and T Jiang*. Anatomical localization of isocitrate dehydrogenase 1 mutation: a voxel-based radiographic study of 146 low-grade gliomas. Eur J Neurol. 2015,22(2):348-54.SCI
73. Z Wang, Z Zhang, Y Wang, G You*, and T Jiang*. Response to "Association of IDH1/2 mutation with preoperative seizure in low-grade gliomas: How strong is the evidence?. Epilepsy Res. 2015,115:145-6.SCI
74. Z L Wang, C B Zhang, J Q Cai, Q B Li, Z Wang, and T Jiang*.Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas. J ExpClin Cancer Res. 2015,34(1):127.SCI
75. W Yan, Y Liu, P Yang, Z Wang, Y You*, and T Jiang*.MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype. Oncotarget. 2015,6(13):11676-82.SCI
76. Y Y Wang, K Wang, S W Li, J F Wang, J Ma, T Jiang*, and J P Dai*. Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas with IDH1 Mutation. AJNR Am J Neuroradiol. 2015,36(11):2023-9.SCI
77. Y Y Wang, T Zhang, S W Li, T Y Qian, X Fan, X X Peng, J Ma, L Wang*, and T Jiang*.Mapping p53 mutations in low-grade glioma: a voxel-based neuroimaging analysis. AJNR Am J Neuroradiol. 2015,36(1):70-6.SCI
78. K Yao, X L Qi, X Mei, and T Jiang*.Gliosarcoma with primitive neuroectodermal, osseous, cartilage and adipocyte differentiation: a case report. Int J ClinExpPathol,. 2015, 8(2):2079-84.SCI
79. C B Zhang, P Zhu, P Yang, J Q Cai, Z L Wang, Q B Li, Z S Bao, W Zhang, and T Jiang*. Identification of high risk anaplastic gliomas by a diagnostic and prognostic signature derived from mRNA expression profiling. Oncotarget. 2015, 6(34): 36643-51.SCI
80. Z Zhong, Z Wang, Y Wang, G You*, and T Jiang*.IDH1/2 mutation is associated with seizure as an initial symptom in low-grade glioma: A report of 311 Chinese adult glioma patients. Epilepsy Res. 2015,109:100-5.SCI
81. J Cai, J Chen, W Zhang, P Yang, C Zhang, M Li, K Yao, H Wang, Q Li, C Jiang*, and T Jiang*.Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors. Oncotarget. 2015,6(20):18105-15.SCI
82. H Hu, Z Wang, Y Liu, C Zhang, M Li, W Zhang, K Wang, J Cai, W Cheng, H Huang, and T Jiang.Genome-wide transcriptional analyses of Chinese patients reveal cell migration is attenuated in IDH1-mutant glioblastomas. Cancer Lett. 2015,357(2): 566-74.SCI
83. M Y Li, Y Y Wang, J Q Cai, C B Zhang, K Y Wang, W Cheng, Y W Liu, W Zhang, and T Jiang*.Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas. PLoS One. 2015,10(6):e**.SCI
84. Y Liu, H Hu, C Zhang, Z Wang, M Li, W Zhang, and T Jiang*. Methylation associated genes contribute to the favorable prognosis of gliomas with mutation. Am J Cancer Res. 2015,5(9): 2745-2755.SCI
85. H Wang, T Tao, W Yan, Y Feng, Y Wang, J Cai, Y You*, T Jiang*, and C Jiang*.Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma. Sci Rep, . 2015,5:13072.SCI
86. Y Wang, X Fan, W Zhang, C Zhang, J Wang, T Jiang*, and L Wang*.Deficiency of very large G-protein-coupled receptor-1 is a risk factor of tumor-related epilepsy: a whole transcriptome sequencing analysis. J Neurooncol. 2015,121(3): 609-16.SCI
87. X Zhou, Y Ren, J Zhang, C Zhang, K Zhang, L Han, L Kong, J Wei, L Chen, J Yang, Q Wang, J Zhang, Y Yang, T Jiang*, M Li*, and C Kang*.HOTAIR is a therapeutic target in glioblastoma. Oncotarget. 2015,6(10): 8353-65.SCI
88. W Yan, R Li, Y Liu, P Yang, Z Wang, C Zhang, Z Bao, W Zhang, Y You, and T Jiang.MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis. Oncotarget. 2014,5(24):12908-15.SCI
89. C B Zhang, Z S Bao, H J Wang, W Yan, Y W Liu, M Y Li, W Zhang, L Chen*, and T Jiang*.Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China. J Cancer Res ClinOncol,. 2014,140(1):45-51.SCI
90. T Zhang, Y Wang, X Fan, J Ma, S Li, T Jiang*, and L Wang*.Anatomical localization of p53 mutated tumors: A radiographic study of human glioblastomas. J NeurolSci. 2014,346(1-2):94-8.SCI
91. Y Wang, X Fan, C Zhang, T Zhang, X Peng, T Qian, J Ma, L Wang, S Li*, and T Jiang*,.Identifying radiographic specificity for phosphatase and tensin homolog and epidermal growth factor receptor changes: a quantitative analysis of glioblastomas. Neuroradiology. 2014, 56(12):1113-20.SCI
92. Zhao-Shi Bao#, Hui-Min Chen#, Ming-Yu Yang#, Chuan-Bao Zhang, Kai Yu, WanLu Ye, Bo-Qiang Hu, Wei Yan, Wei Zhang, Johnny Akers, Valya Ramakrishnan, Jie Li, Bob Carter, Yan-Wei Liu, Hui-Min Hu, Zheng Wang, Ming-Yang Li, Kun Yao,XiaoGuang Qiu, Chun-Sheng Kang, XiaoDong Su*, Clark C. Chen*, Tao Jiang*.RNA-Seq of 272 gliomas revealed a novel, recurrent PTPRZ-MET fusion transcript in secondary glioblastomas. Genome Research. 2014,24(11):1765-73.SCI
93. Z Bao, Y Feng, H Wang, C Zhang, L Sun, Z Yan, Q Liu, T Guo, M Li, X Yang, C Jiang, Q Zhang, and T Jiang.Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma. Oncol Rep. 2014, 32(1):250-60.SCI
94. J Cai#, P Yang#, C Zhang#, W Zhang#, Y Liu, Z Bao, X Liu, W Du, H Wang, T Jiang*, and C Jiang*,.ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples samples. Oncotarget. 2014,5(9):2551-61.SCI
95. Z S Bao#, G You, W B Li, and T Jiang*.A single aspergillus fumigatus intracranial abscess in an immunocompetent patient with parietal lobe tumorectomy. World J SurgOncol. 2014,12(1):181.SCI
96. T Guo#, Y Feng, Q Liu, X Yang, T Jiang*, Y Chen*, and Q Zhang*.MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R. TumourBiol. 2014,35(11):11269-75.SCI
97. Y Liu#, H Hu#, K Wang, C Zhang, Y Wang, K Yao, P Yang, L Han, C Kang, W Zhang*, and T Jiang*.Multidimensional analysis of gene expression reveals TGFB1I1-induced EMT contributes to malignant progression of astrocytomas. Oncotarget. 2014,5(24):12593-606.SCI
98. Z S Bao#, M Y Li#, J Y Wang, C B Zhang, H J Wang, W Yan, Y W Liu, W Zhang, L Chen, and T Jiang*.Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling. CNS NeurosciTher. 2014,20(2):112-8.SCI
99. Y Feng#, Z Wang#, Z Bao, W Yan, G You, Y Wang, H Hu, W Zhang, Q Zhang, and T Jiang*.SOCS3 promoter hypermethylation is a favorable prognosticator and a novel indicator for G-CIMP-positive GBM patients. PLoS One. 2014,9(3):e91829.SCI
100. Y Sun#, W Zhang#, D Chen, Y Lv, J Zheng, H Lilljebjorn, L Ran, Z Bao, C Soneson, H O Sjogren, L G Salford, J Ji, P J French, T Fioretos, T Jiang*, and X Fan*.A glioma classification scheme based on coexpression modules of EGFR and PDGFRA. Proc Natl AcadSci . 2014,111(9):3538-43.SCI
101. Y Wang#, X Chen, Z Zhang, S Li, B Chen, C Wu, L Wang, X Zhang, J Wang, L Chen, and T Jiang*.Comparison of the clinical efficacy of temozolomide (TMZ) versus nimustine (ACNU)-based chemotherapy in newly diagnosed glioblastoma. Neurosurg Rev. 2014,37(1):73-8.SCI
102. P Yang, G You, W Zhang, Y Wang, Y Wang, K Yao, and T Jiang*.Correlation of preoperative seizures with clinicopathological factors and prognosis in anaplastic gliomas: a report of 198 patients from China. seizure. 2014, 23(10):844-51.SCI
103. Y Wang, X Fan, C Zhang, T Zhang, X Peng, S Li, L Wang, J Ma, and T Jiang.Anatomical specificity of O6-methylguanine DNA methyltransferase protein expression in glioblastomas. J Neurooncol. 2014, 120(2):331-7.SCI
104. Y Wang, X Fan, C Zhang, T Zhang, X Peng, T Qian, J Ma, L Wang, S Li, and T Jiang.Identifying radiographic specificity for phosphatase and tensin homolog and epidermal growth factor receptor changes: a quantitative analysis of glioblastomas. Neuroradiology. 2014,56(12):1113-20.SCI
105. Zhao P, Zhao L, Zou P, Lu A, Liu N, Yan W, Kang C, Fu Z, You Y, Jiang T*.Genetic oxidative stress variants and glioma risk in a Chinese population: a hospital-based case--control study. BMC Cancer. 2013,12(1):617.SCI
106. Chen YD, Zhang X, Qiu XG, Li J, Yuan Q, Jiang T*, Yang M.Functional FEN1 genetic variants and haplotypes are associated with glioma risk. J Neurooncol. 2013,111(2):145-51.SCI
107. Wang Y, Jiang T*.Understanding High Grade Glioma: Molecular Mechanism, Therapy and Comprehensive Management. Cancer Lett. 2013,331(2):139-46.SCI
108. Yan ZH, Bao ZS, Yan W, Liu YW, Zhang CB, Wang HJ, Feng Y, Wang YZ, Zhang W, You G, Zhang QG, Jiang T*.Upregulation of DLX2 confers a poor prognosis in glioblastoma patients by inducing a proliferative phenotype. Curr Mol Med. 2013,13(3):438-45.SCI
109. Zhang JX, Zhang J, Yan W, Wang YY, Han L, Yue X, Liu N, You YP, Jiang T*, Pu PY, Kang CS.Unique genome-wide map of TCF4and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma. Neuro-Oncology. 2013,15(3):279-89.SCI
110. Zhang W, Yan W, You G, Bao Z, Wang Y, Liu Y, You Y, Jiang T*.Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP- primary glioblastoma. Cancer Lett. 2013,328(1):120-5.SCI
111. Zhang W, Zhang J, Hoadley K, Kushwaha D, Ramakrishnan V, Li S, Kang C, You Y, Jiang C, Song SW, Jiang T*, Chen CC.miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression. Neuro Oncol. 2012,14(6):712-9.SCI
112. You G, Sha ZY, Yan W, Zhang W, Wang YZ, Li SW, Sang L, Wang Z, Li GL, Li SW, Song YJ, Kang CS, Jiang T*.Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study. Neuro-Oncology. 2012,14(2):230-41.SCI
113. Chen Q, Chen XZ, Wang JM, Li SW, Jiang T*, Dai JP*.Intracranial Meningeal Hemangiopericytomas in Children and Adolescents: CT and MR Imaging Findings. AJNR Am J Neuroradiol. 2012,33(1):195-9.SCI
114. Li S, Yan C, Huang L, Qiu X, Wang Z, Jiang T*.Molecular prognostic factors of anaplastic oligodendroglial tumors and its relationship: a single institutional review of 77 patients from China. Neuro-Oncology. 2012,14(1):109-116.SCI
115. Yan W, Zhang W, You G, Bao Z, Wang Y, Liu Y, Kang C, You Y, Wang L, Jiang T*.Correlation of IDH1 mutation with clinicopathologic factors and prognosis in primary glioblastoma: a single institutional review of 118 patients from China. PLoS One. 2012,7(1):e30339.SCI
116. Wang Y, Li S, Chen L, You G, Bao Z, Yan W, Shi Z, Chen Y, Yao K, Zhang W, Kang C, Jiang T*.Glioblastoma with oligodendroglioma component: distinct clinical behavior, genetic alterations and outcome. Neuro-Oncology. 2012,14(4):518-25.SCI
117. Li WB, Tang K, Zhang W, Yan W, You G, Li SW, Zhang L, Huang YJ, Jiang T*.Relationship between magnetic resonance imaging and molecular pathology in patients with glioblastoma multiforme. Chinese Medical Journal. 2011,124(17):2589-2592.SCI
118. Yan W, Zhang W, Jiang T*.Oncogene addiction in gliomas: implications for molecular targeted therapy. Journal of Experimental & Clinical Cancer Research . 2011,30(58):1-5.SCI
119. Jiang T*, Tang GF, Lin Y, Peng XX, Zhang X, Zhai XW, Peng X, Yang JQ, Huang HE, Wu NF, Chen XJ, Xing HX, Su TY, Wang ZC.Prevalence estimates for primary brain tumors in China: a multi-center cross-sectional study. Chinese Medical Journal. 2011,124(17):2578-2583.SCI
120. Kai Tang,Tao Jiang*.Clinical correlation of MGMT protein expression and promoter methylation in Chinese glioblastoma patients. Med Oncol. 2011,in press:-.SCI
121. Lei Huang,Gan You,Tao Jiang* .Correlation between tumor-related seizures and molecular genetic profile in 103 Chinese patients with low-grade gliomas: A preliminary study. Journal of the Neurological Sciences. 2011,302:63–67.SCI
122. Kai Huang,Tao Jiang*.MicroRNA roles in beta-catenin pathway. Molecular Cancer. 2010,252:1-12.SCI
123. Lei Han1,Tao Jiang*.Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of β-catenin-mediated transcription. Brain Research. 2010,1366:9-17.SCI
124. Xiao Yue,Tao Jiang*.Interruption of β-catenin supresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells. Brain Research. 2010,1366:27-37.SCI
125. 王永志，江涛*.双语脑语言转换和语言代表区的术中直接电刺激研究. 中国微侵袭神经外科杂. 2009,14(1):6-9.核心期刊
126. 吴陈兴，江涛*.累及Broca区低级别胶质瘤的BOLD-fMRI及语言功能区的可塑性研究. 中国微侵袭神经外科杂. 2009,14(1):10-13.核心期刊
127. 江涛.大脑胶质瘤的分子病理分型与化疗. 中国微侵袭神经外科杂. 2009,14(1):1-2.核心期刊
128. 仪晓立，江涛*.功能区胶质瘤手术前后语言功能皮质的变化. 中国微侵袭神经外科杂. 2009,14(1):3-5.核心期刊
129. 周开甲,江涛*.血浆IGFBP-2在脑胶质母细胞瘤治疗前后变化. 中华神经外科杂志 . 2008,24（7）:490-492.核心期刊
130. 陈绪珠，江涛*.低级别脑胶质瘤的手术时机：18例动态影像学观察. 中国微侵袭神经外科杂. 2008,13(6):120-122.核心期刊
131. 陈宝师，江涛*.抗血管生成靶向药物治疗恶性胶质瘤的临床研究. 中国现代神经疾病杂志. 2008,8(5):432-436.核心期刊
132. 张忠，江涛*.术中功能定位切除辅助运动区低级别胶质瘤 . 中华神经外科杂志. 2008,24（1）:35-37.核心期刊
133. 宗淼，江涛*.少枝胶质细胞瘤的动态生长变化. 中华神经外科杂志 . 2008,24（5）:363-365.核心期刊
134. 张忠，江涛*.术中实时超声在脑功能区胶质瘤手术中的应用价值 . 中国微侵袭神经外科杂志. 2007,12(11):497-498.核心期刊
135. 周开甲，江涛*.IGFBP-2在高级别脑胶质瘤中作用的研究进展 . 中国微侵袭神经外科杂志. 2007,12(6):285－288.核心期刊
136. 周开甲，江涛*.胶质细胞瘤血浆IGFBP-2浓度的动态监测及其临床意义 . 中国微侵袭神经外科杂志. 2007,12(11):510-513.核心期刊
137. 江涛.脑胶质瘤的分子靶向治疗 . 中华神经外科杂志. 2007,23（9）:641-642.核心期刊
138. 张忠，江涛*.唤醒麻醉和术中功能定位切除语言区胶质瘤 . 中华神经外科杂志. 2007,23（9）:643-645.核心期刊
139. 谢坚，江涛*.应用脑功能磁共振成像及弥散张量成像技术辅助切除脑运动区皮层深部区域的胶质瘤. 中华外科杂志. 2006,44（9）:1283-1284.核心期刊
140. Yiwen Cao,Chuanlu Jiang,Tao Jiang*.Molecular Cloning and Preliminary Analysis of a Fragile Site Associated Gene . Biomedical and Enviromental Sciences. 2006,19:392-398.SCI
141. Tao Jiang*.Role of 3T High Field BOLD fMRI in Brain Cortical Mapping for Glioma Involving Eloquent Areas. MIRA. 2006,LNCS 4091:92-99.SCI
142. 江涛*,高之宪.临床研究生带教体会——“受之与渔”,而非“受之与鱼”. 首都医科大学学报. 2006,S1:226-228.核心期刊
143. 宗淼，江涛*.综合治疗大脑半球胶质瘤的临床研究. 中华外科杂志. 2006,44（9）:1282-1283.核心期刊
144. 李子孝，江涛*.功能和纤维成像在脑功能区胶质瘤中的应用. 中华外科杂志. 2006,44（9）:1275-1279.核心期刊
145. 江涛.胶质瘤的分子病理分类和靶向治疗的研究. 中华外科杂志. 2006,44（9）:1292-1294.核心期刊
146. 江涛*, 陈新中 ,谢坚.功能区胶质瘤的术中直接电刺激判断核心手术技术. 中国微侵袭神经外科杂志. 2005,10（4）:148-150.核心期刊
147. 江涛 *,于春江, 王忠诚.听神经瘤术后听力保留三个问题. 中国微侵袭神经外科杂志. 2001,6(1):3-5.核心期刊
148. 江涛 * ,王忠诚 ,于春江.听神经瘤听力保留的显微解剖学研究. 中国微侵袭神经外科杂志. 2001,6(1):38-42.核心期刊
149. 江涛 *,于春江 ,郭尔安 ,关树森.大型前庭神经雪旺细胞瘤与面神经病理解剖关系的临床研究. 中华医学杂志. 2001,81(9):536-537.核心期刊
150. 江涛*, 于春江, 郭尔安.听神经瘤枕下乙状窦后入路开颅技术的改进临床研究. 中国微侵袭神经外科杂志. 2001,6(1):19-21.核心期刊
151. 江涛* , 于春江.岩-斜区脑膜瘤显微外科治疗进展. 中国微侵袭神经外科杂志. 2001,6(2):126-127 .核心期刊
152. 江涛* , 丁艳玲 , 于春江.经岩骨侧方入路手术切除斜坡表皮样囊肿. 中华医学杂志. 2000,80（3）:200-201.核心期刊
153. 江涛* ,王忠诚 ,于春江, 陈菲 ,王风梅.经岩骨乙状窦前入路-骨迷路与面神经管保护的解剖与临床研究. 中国微侵袭神经外科杂志. 2000,5（2）:65-68.核心期刊
154. 江涛 *,于春江 ,张亚卓, 王忠诚.脑干腹侧方解剖间隙观察与研究. 中华神经外科杂志. 2000,1（16）:24-28.核心期刊
155. 江涛* ,王忠诚 ,于春江, 刘吉祥, 陈菲 .单侧枕下乙状窦后入路磨开内耳道后壁解剖学研究与骨迷路保护. 中华神经外科杂志. 1999,15（4）:196-199.核心期刊
156. 江涛* , 王忠诚 ,于春江 ,张保中, 张纪.海绵窦相关显微外科相关三角解剖学研究. 中华神经外科杂. 1999,15（1）:45-49.核心期刊
157. 江涛*, 于春江, 王忠诚.CPA肿瘤术后听力保存若干问题. 国外医学神经病学神经外科学分册. 1998,25（4）:197-201.核心期刊
158. 江涛* , 刘相珍, 戴钦舜 ,陈会荣 , 黄正松.脑血管畸形栓塞后手术切除. 中华神经外科杂志. 1998,14（4）:241-242.核心期刊
159. 江涛 *, 戴钦舜, 刘恩重 , 赵立富 , 李昌盛.大脑中动脉间断阻断安全时间的实验研究. 中国微侵袭神经外科杂志. 1998,3（2）:112-114.核心期刊
160. 江涛* , 戴黎萌 , 戴钦舜.白细胞，单核细胞与缺血复流后二次脑损伤. 基础医学与临床. 1998,18（2）:12-14.核心期刊
161. 江涛* ， 王忠诚 ，于春江， 陈菲 ，王风梅.远外侧经髁入路巨显微解剖学研究. 中华医学杂志. 1998,78（6）:448-451.核心期刊
162. 江涛* , 戴钦舜 , 刘恩重 , 赵立富 , 李昌盛.脑缺血-再灌注损伤中兴奋氨基酸的变化. 中华神经外科杂志. 1997,13（4）:219-221.核心期刊
163. 江涛* , 黄正松 , 戴钦舜 ,刘恩重.选择性、超选择性血管内溶栓治疗闭塞性脑血管病. 哈尔滨医科大学学报. 1995,29（3）:268-269.核心期刊
164. 江涛* , 黄正松 ,戴钦舜 , 刘恩重.不用开颅的脑缺血-再灌注模型的制备. 国外医学脑血管疾病分册. 1994,2（13）:38-39.核心期刊
主编或副主编的著作/译著
1. 《胶质瘤临床医生使用手册》,主编,复旦大学出版社,201608
2. 《脑胶质瘤的临床治疗技术与进展》,主编,人民卫生出版社,201109
3. 《脑肿瘤化学治疗》,主编,人民卫生出版社,200809
4. 《脑胶质瘤》,主编,人民卫生出版社,200704
5. 《海绵窦：显微解剖、手术入路、神经影像》,主编,中国协和医科大学出版社,200601
6. 《脑室外科手术学》,主编,中国协和医科大学出版社,200110
重要奖项
1. - 北京 市级人才 201909
2. 脑胶质瘤诊疗关键技术创新与推广应用 国家科学技术进步奖 二等奖 201712
3. 北京市先进工作者 市级人才 2015
4. 北京市“高创计划”领军人才 市级人才 2015
5. 脑胶质瘤诊疗技术创新研究与临床应用 中国抗癌协会科技奖 二等奖 201409
6. 科技北京百名领军人才 科技北京百名领军人才 省部级 201212
7. 教育部科技进步奖 教育部科技进步一等奖 省部级 201212
8. 2009年北京市新世纪百千万人才工程 市十级人才 200908
9. 大脑功能区病变手术新技术研究 广东省科技进步奖 二等奖 200908
10. 2008年北京市新世纪百千万人才工程 市级人选 200810
11. 2008年中国医师协会神经外科医师分会分会神经外科医师奖获得者 神经外科医师奖 200807
12. 王忠诚中国神经外科医师年度奖 2007年度青年奖 200803
13. 脑深部肿瘤显微手术及相关基础研究 中华医学科技奖 二等奖 200612
14. 2005年北京市新世纪百千万人才工程 市百级人才 200508
15. 神经外科手术中诱发电位监测的研究 北京市科学技术进步奖 三等奖 200212
16. 前庭神经雪旺氏细胞（听神经瘤）显微外科治疗 北京市科学技术进步奖 三等奖 200212
17. 颅底外科手术入路显微解剖与临床研究 北京市科学技术进步奖 三等奖 200012
18. 北京市卫生局第七届青年科技论文 优秀奖 200004
19. 卫生部国际交流中心-日本第一制药医药学奖学金 医药学奖学金 第一 1995